Medicina Global e Humanitária
Estudo randomizado | Tratamento antirretroviral de baixo custo e de fácil adesão, baseado em dolutegravir, como terapia de primeira ou segunda linha foi não inferior ao tratamento padrão da infecção por HIV-1 em crianças.
10 Jan, 2022 | 12:13hDolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: Easy-to-take medicine better at suppressing HIV in children – University College London
Comentários no Twitter
Dolutegravir-based antiretroviral therapy was compared with standard care in children and adolescents starting first- or second-line therapy for HIV type 1 infection. Dolutegravir-based ART was superior to standard-care ART. https://t.co/PP0XaEVswO pic.twitter.com/pQvhjdXcUk
— NEJM (@NEJM) December 29, 2021
Visual Abstract: Dolutegravir as First- or Second-Line HIV Treatment in Children https://t.co/2RIg9uH2V1 pic.twitter.com/mDr1Z6l6CJ
— NEJM (@NEJM) January 4, 2022
Relatório OMS | Mais de meio bilhão de pessoas foram empurradas para a pobreza extrema em decorrência dos custos do cuidado de saúde.
14 Dez, 2021 | 16:10hComunicado de imprensa: More than half a billion people pushed or pushed further into extreme poverty due to health care costs – World Health Organization
Relatório 1: Tracking Universal Health Coverage: 2021 Global monitoring report – World Health Organization
Relatório 2: Global monitoring report on financial protection in health 2021 – World Health Organization
Relatório OMS | Mais casos de malária e mortes em 2020 associados com interrupções no cuidado causadas pela COVID-19.
7 Dez, 2021 | 11:38hComunicado de imprensa: More malaria cases and deaths in 2020 linked to COVID-19 disruptions – World Health Organization
Relatório: World Malaria Report 2021 – World Health Organization
Comentários:
More people died of malaria in 2020 than in 2019. Here’s why – NPR
Malaria kills 180,000 more people annually than previously thought, says WHO – The Guardian
Comentário no Twitter (fio – clique para saber mais)
#COVID19 pandemic has disrupted #malaria services, leading to a marked increase in cases and deaths: 14 million more cases in 2020 compared to 2019, and 69,000 more deaths – new report.
➡️https://t.co/M9sNo2Pn4u #EndMalaria pic.twitter.com/g6MKFVpQKf— World Health Organization (WHO) (@WHO) December 6, 2021
O impacto global do câncer em adolescentes e jovens adultos em 2019: análise sistemática para o Global Burden of Disease Study 2019.
6 Dez, 2021 | 16:02hComentário convidado: Burden of cancer in adolescents and young adults – The Lancet Oncology
Estimativas globais da supressão viral em 31 países mostram que muitos portadores do vírus HIV falharam em atingir uma supressão viral durável.
1 Dez, 2021 | 15:25hComunicado de imprensa: Too many people with HIV fail to achieve durable viral suppression – NIH News Releases
Estudo original: Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries – The Lancet HIV (link para o resumo – $ para o texto completo)
Revisão | Prevenção de infecções emergentes em crianças.
23 Nov, 2021 | 15:33hPrevention of Emerging Infections in Children – Pediatric Clinics of North America
[Ainda não publicado] Pesquisadores afirmam que dose única de vacina contra HPV é altamente eficaz – “Resultado de estudo randomizado e controlado no Quênia traz novo ânimo para eliminar o câncer de colo de útero no mundo.”
22 Nov, 2021 | 09:23hConteúdos relacionados:
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination
Meta-Analysis: Population-level Impact of HPV Vaccination Programs
Progresso global da tuberculose foi revertido pela pandemia de COVID-19.
19 Nov, 2021 | 13:14hGlobal tuberculosis progress reversed by COVID-19 pandemic – The Lancet Respiratory Diseases
Conteúdos relacionados:
How COVID is derailing the fight against HIV, TB and malaria.
How COVID hurt the fight against other dangerous diseases
World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis
Tuberculosis and Covid-19: Fighting a deadly syndemic
Comentário no Twitter
NEWS—Global #tuberculosis progress reversed by #COVID19 pandemic
"Due to the delayed effects from #COVID19, #tuberculosis deaths are projected to rise again in 2022 while the world readjusts to a new normality and services resume."
Read more here: https://t.co/tWVXswZsvs
— The Lancet Respiratory Medicine (@LancetRespirMed) November 3, 2021
Novo relatório da OMS mapeia as barreiras à disponibilidade de insulina e sugere ações que promovam o acesso universal – “100 anos depois de sua descoberta, a insulina ainda está fora do alcance de muitos que vivem com diabetes.”
16 Nov, 2021 | 12:34hComunicado de imprensa: New WHO report maps barriers to insulin availability and suggests actions to promote universal access – World Health Organization
Relatório: Keeping the 100-year-old promise: making insulin access universal – World Health Organization
Comentário: Half the People Living with Diabetes Can’t Afford Insulin, WHO Report Shows – Health Policy Watch
Conteúdos relacionados:
Editorial | Insulin for all: a hope yet to be realized.
One hundred years of insulin therapy.
Comentário no Twitter (fio – clique para saber mais)
The 🆕 WHO report on global access to #insulin shows how a century after its discovery, insulin remains inaccessible or unaffordable for many children and adults living with #diabetes around the 🌍🌎🌏.
More here 👉https://t.co/kcaqh6tYO1
— World Health Organization (WHO) (@WHO) November 12, 2021
#AHA21 – Estudo randomizado | Entre crianças e adolescentes submetidos a rastreamento ecocardiográfico e diagnosticados com doença cardíaca reumática latente, antibioticoprofilaxia secundária com penicilina G benzatina por 2 anos foi associada com redução da progressão ecocardiográfica (0,8 vs, 8,2% no grupo controle).
15 Nov, 2021 | 13:53hSecondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários:
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease – American College of Cardiology
Comentários no Twitter
One of most important studies ever Rheumatic Heart Disease @NEJM https://t.co/U8FuNHLqCJ RCT evidence 2ry prophylaxis reduces progression latent RhD pic.twitter.com/UycTElr7QM
— Michael Marks (@dr_michaelmarks) November 13, 2021
Penicillin slowed the devastating impact of rheumatic heart disease among children in Uganda. Findings of a large-scale, randomized controlled trial were completed in Uganda. Group A strep underlies rheumatic heart disease. New England Journal of Medicine https://t.co/1PKFJ12FvC
— delthia ricks 🔬 (@DelthiaRicks) November 13, 2021